Atlas Trials

Ventus Therapeutics U.S., Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ventus Therapeutics U.S., Inc.

RecordFirmDate
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus (NCT07260877)Ventus Therapeutics U.S., Inc.2025-12-03
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease (NCT06822517)Ventus Therapeutics U.S., Inc.2025-03-05

Track Ventus Therapeutics U.S., Inc. automatically

Every clearance here is in the API, with alerts when new ones post.